Bright Eye Hospital Group Co., Ltd.

Company Profile

As a leading non-public eye care chain medical institution in China, the company has cultivated unique competitive advantages through over two decades of dedicated efforts in regional expansion, mergers and acquisitions, business structure, medical technology, talent development, data-driven and intelligent operations, and ESG governance, laying a solid foundation for its sustained and healthy development. 1.Advantages of Regional Integration Cluster Layout The company adheres to a strategic layout of "national chain + regional integration," closely aligning with China's regional economic development patterns and population mobility trends. It prioritizes the establishment of ophthalmology medical institutions in core cities such as municipalities directly under the central government and provincial capitals, using these as hubs to extend its influence to surrounding areas. By deploying multiple ophthalmology medical institutions within the same region, the company achieves a model of expert resource sharing, unified equipment utilization, two-way patient referrals, and joint brand promotion. This approach breaks the boundaries of single-hospital resources, enabling the efficient flow of high-quality medical resources across the region. As a result, it significantly enhances the overall service capabilities and market competitiveness of the region, forming a robust, replicable regional integration development model. 2.Advantages of Precise and Efficient M&A Integration While continuously expanding its high-tier urban network through self-development, the company has keenly seized industry consolidation opportunities, swiftly entering lower-tier markets through strategic acquisitions, forming a development path of "self-development as the primary approach, supplemented by acquisitions." Through a series of precise acquisitions, the company has refined its business layout in key regions. After years of deep industry engagement and acquisition practice, the company has established a scientific and rigorous target screening and evaluation system, accumulating extensive mature experience in accurately identifying regional leaders and uncovering high-potential value targets. The market-validated acquisition management model has become the core support for the company's strategy of dual-driven growth—both internal expansion and external extension—providing solid backing for its ongoing optimization of nationwide operations and consolidation of industry leadership. 3.Advantages of continuous optimization of business structure The various business segments of the company have maintained steady development in a complex market environment, and the business structure has shown a good trend of continuous optimization. The development of the company's four major business segments, including refractive, cataract, optometry, and comprehensive eye disease, is balanced. A diversified business structure can effectively diversify the risks brought by fluctuations in a single business. At the same time, good synergies have been formed between various business segments. The optometry business has provided a large number of potential customers to the refractive business, and the comprehensive eye disease business has provided technical support for the cataract and refractive business. 4.Patient centered medical technology and quality system The company always regards medical quality and safety as the foundation of development, establishes stable strategic partnerships with internationally renowned medical device and drug manufacturers, and continues to introduce cutting-edge equipment, innovative products, and advanced technologies. In order to improve the diagnosis and treatment level of difficult cases, the company has established Multidisciplinary Diagnosis and Treatment (MDT) centers or implemented standardized MDT models in multiple affiliated hospitals, integrating resources from multiple sub-specialty experts, and carried out joint diagnosis and treatment for complex cases, effectively ensuring the safety and effectiveness of patient diagnosis and treatment. 5.Advantages of integrated and collaborative development of medical education and research The company has always regarded medical technology innovation and academic development as the core driving force for high-quality development. It has established a research and academic guidance committee composed of well-known ophthalmic experts to coordinate the group's scientific research planning, key project implementation, and external cooperation and coordination between industry, academia, and research, providing systematic guidance and resource guarantee for academic work and continuously improving technological innovation capabilities. During the reporting period, the company made landmark progress in the construction of an integrated platform for medical teaching and research. It jointly established an ophthalmology center and an optometry research center with Shanghai University School of Medicine, and carried out in-depth cooperation around talent joint training, clinical scientific research, and technological achievement transformation. At the same time, the company actively expands cooperation with well-known universities at home and abroad, focusing on areas such as myopia prevention and control, visual health management, etc., accelerating the transformation of scientific research achievements into clinical applications, and continuously enhancing core technological competitiveness and academic influence. 6.A refined operation system driven by digitalization The company conforms to the wave of digital transformation in the medical industry, comprehensively upgrades its digital development strategy, and focuses on the digital transformation of the entire hospital process and the construction of a smart hospital system. By deploying a new generation of integrated digital management information system, the entire diagnosis and treatment process has been digitized, significantly optimizing the patient experience and hospital operation efficiency. The company has unified the data standards of its core business system and established a group level comprehensive data center, breaking down information silos and achieving real-time communication and sharing of diagnosis and treatment data and operational data across the entire domain. The company has built a digital infrastructure base with "one group data center, two intelligent service platforms, and six core business systems" as its core, and actively promotes the deep integration of artificial intelligence and ophthalmic diagnosis and treatment scenarios, injecting new digital impetus into the high-quality development of hospitals. 7.Responsible ESG governance and brand building The company attaches great importance to sustainable development and has established a comprehensive ESG management system covering the environment, society, and corporate governance. The ESG concept is deeply integrated into the entire process of strategic planning, business decision-making, and daily operations. The company continues to promote the construction of green hospitals, actively fulfills social responsibilities, regularly carries out public welfare activities for eye health, and continuously improves the corporate governance structure and compliance management. Through multi-dimensional collaboration of technology leadership, expert empowerment, service upgrades, and public welfare practices, the company continues to build a differentiated brand image, steadily increasing its brand influence and reputation, and has become a trusted professional ophthalmic medical brand for patients across the country.